EPAS1 and breast cancer: In breast cancer, HIF-2α is overexpressed in 29% of primary lesions and 69% of breast metastases but is not expressed in benign tumors [33], because hypoxia- sensitive gene expression is induced in rapidly growing tumors with a hypoxic core [34,35].